MetLife Stock Has A 44% Upside To Its Pre-Inflation Peak
MetLife stock (NYSE: MET) currently trades around $50 per share, around 30% below (more than 44% upside) its level of approximately $72 on April 20, 2022 (pre-inflation shock high), and has the potential for sizable gains. MetLife saw its stock trading at around $63 at the end of June 2022, just before the Fed started increasing rates, and is still 20% below that level. In comparison, the S&P 500 gained about 13% during this period. The stock price has suffered over recent months due to the fear of an economic crisis after the collapse of Silicon Valley Bank (SVB), coupled with lower-than-expected results in Q4 2022 and Q1 2023.
Returning to the pre-inflation shock level means that MET stock will have to gain more than 44% from here. However, we do not believe that will materialize in a quarter or two because of investor concerns over a potential recession due to tough macroeconomic conditions. Notably, the pre-inflation shock high is slightly below MetLife’s valuation estimate of $75 per share, which also suggests that the stock is undervalued.
Our detailed analysis of MetLife’s upside post-inflation shock captures trends in the company’s stock during the turbulent market conditions seen over 2022 and compares these trends to the stock’s performance during the 2008 recession.
- What To Expect From MetLife Stock In 2025?
- MetLife Stock Is Trailing S&P500 In YTD Returns, What To Expect?
- Dropping 5% Since The Start Of 2023, Can MetLife Stock Rebound?
- Trailing The S&P Index By 30% YTD, Can MetLife Stock Recoup Its Losses?
- Where Is MetLife Stock Headed?
- Is MetLife Stock Fairly Priced?
2022 Inflation Shock
Timeline of Inflation Shock So Far:
- 2020 – early 2021: Increase in money supply to cushion the impact of lockdowns led to high demand for goods; producers unable to match up.
- Early 2021: Shipping snarls and worker shortages from the coronavirus pandemic continue to hurt supply
- April 2021: Inflation rates cross 4% and increase rapidly
- Early 2022: Energy and food prices spike due to Russian invasion of Ukraine. Fed begins its rate hike process
- June 2022: Inflation levels peak at 9% – the highest level in 40 years. S&P 500 index declines more than 20% from peak levels.
- July – September 2022: Fed hikes interest rates aggressively – resulting in an initial recovery in the S&P 500 followed by another sharp decline
- Since October 2022: Fed continues rate hike process; improving market sentiments help S&P500 recoup some of its losses
In contrast, here’s how MET stock and the broader market performed during the 2007/2008 crisis.
Timeline of 2007-08 Crisis
- 10/1/2007: Approximate pre-crisis peak in S&P 500 index
- 9/1/2008 – 10/1/2008: Accelerated market decline corresponding to Lehman bankruptcy filing (9/15/08)
- 3/1/2009: Approximate bottoming out of S&P 500 index
- 12/31/2009: Initial recovery to levels before accelerated decline (around 9/1/2008)
MET and S&P 500 Performance During 2007-08 Crisis
MetLife stock declined from nearly $65 in September 2007 (pre-crisis peak) to below $17 in March 2009 (as the markets bottomed out), implying MET stock lost almost 74% of its pre-crisis value. It recovered post the 2008 crisis to levels of around $32 in early 2010, rising 92% between March 2009 and January 2010. The S&P 500 Index saw a decline of 51%, falling from levels of 1,540 in September 2007 to 757 in March 2009. It then rallied 48% between March 2009 and January 2010 to reach levels of 1,124.
MET Fundamentals Over Recent Years
MetLife revenues decreased by 3% from $69.6 billion in 2019 to $67.8 billion in 2020 due to a drop in net investment income, before increasing by 5% in 2021. The top line again suffered a 2% drop in 2022 to $69.9 billion due to lower net investment income and net investment losses, despite strong growth in premiums.
Similarly, earnings decreased from $6.10 in 2019 to $5.72 in 2020, before improving to $7.36 in 2021. It declined to $2.93 in 2022, mainly due to an unfavorable increase in total expenses as a % of revenues.
Conclusion
With the Fed’s efforts to tame runaway inflation rates helping market sentiments, we believe MetLife (MET) stock has the potential for strong gains (more than 44%) once fears of a potential recession are allayed.
What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since 2016.
Returns | Jun 2023 MTD [1] |
2023 YTD [1] |
2017-23 Total [2] |
MET Return | 2% | -30% | 2% |
S&P 500 Return | 2% | 11% | 90% |
Trefis Multi-Strategy Portfolio | 1% | 10% | 248% |
[1] Month-to-date and year-to-date as of 6/2/2023
[2] Cumulative total returns since the end of 2016
Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates